Myriad Genetics Earnings Report: Q4 Overview
Benzinga Insights 8 months ago
Earnings
Myriad Genetics (NASDAQ:MYGN) announced its Q4 earnings on Monday, February 23, 2026 at 04:05 PM.
Here's a breakdown of the earnings report.
Earnings
Myriad Genetics beat estimated earnings by 180.0%, reporting an EPS of $0.04 versus an estimate of $-0.05.
Revenue was down $800 thousand from the same period last year.
Past Earnings Performance
In the previous quarter, the company beat on EPS by $0.05, resulting in a 21.03% drop change in the share price the following day.
Here's a look at Myriad Genetics's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.05 | -0.05 | -0.05 | 0.03 |
| EPS Actual | 0 | 0.05 | -0.03 | 0.03 |
| Revenue Estimate | 205.17M | 202.14M | 200.51M | 210.35M |
| Revenue Actual | 205.70M | 213.10M | 195.90M | 210.60M |
To track all earnings releases for Myriad Genetics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.